Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.

Показать другие версии (2)

BACKGROUND: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. Rimonabant also seeks to address many smokers' reluctance to pers...

Полное описание

Библиографические подробности
Главные авторы:	Cahill, K, Ussher, M
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2007)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2007)

Cannabinoid type 1 receptor antagonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2011)

Cannabinoid type 1 receptor antagonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2011)

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.
по: Horder, J, и др.
Опубликовано: (2012)

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
по: Horder, J, и др.
Опубликовано: (2012)

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol
по: José Antonio López-Moreno, и др.
Опубликовано: (2007-02-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
по: Taryn Bosquez-Berger, и др.
Опубликовано: (2023-08-01)

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.
по: Horder, J, и др.
Опубликовано: (2009)

Opioid antagonists for smoking cessation
по: David, S, и др.
Опубликовано: (2009)

Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
по: Heppenstall Charlotte, и др.
Опубликовано: (2012-07-01)

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.
по: Horder, J, и др.
Опубликовано: (2010)

Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice
по: Eduardo A. V. Marinho, и др.
Опубликовано: (2023-02-01)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
по: Li Zhao, и др.
Опубликовано: (2021-04-01)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2007)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2011)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2008)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2012)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2010)

Opioid antagonists for smoking cessation
по: David, S, и др.
Опубликовано: (2013)

Nicotine receptor partial agonists for smoking cessation.
по: Cahill, C, и др.
Опубликовано: (2016)

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
по: Kirk A Bronander, и др.
Опубликовано: (2007-05-01)

Veraliprida y rimonabant
по: Flavia Vidal
Опубликовано: (2007-09-01)

Nicotine receptor partial agonists for smoking cessation
по: Kate Cahill, и др.

Workplace interventions for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2014)

Workplace interventions for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2008)

Exercise interventions for smoking cessation
по: Ussher, M, и др.
Опубликовано: (2019)

Mecamylamine (a nicotine antagonist) for smoking cessation.
по: Lancaster, T, и др.
Опубликовано: (2000)

Competitions and incentives for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2011)

Pharmacological treatments for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2014)

Competitions and incentives for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2008)

Competitions and incentives for smoking cessation
по: Cahill, K, и др.
Опубликовано: (2011)

Rimonabant: From RIO to Ban
по: Amir H. Sam, и др.
Опубликовано: (2011-01-01)

Rimonabant for treating tobacco dependence
по: Michael B Steinberg, и др.
Опубликовано: (2007-07-01)

Antidepressants for smoking cessation.
по: Hughes, JR, и др.
Опубликовано: (2014)

Quit and Win contests for smoking cessation
по: Cahill, K, и др.
Опубликовано: (2008)

Quit and Win contests for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2008)

Quit and Win contests for smoking cessation.
по: Cahill, K, и др.
Опубликовано: (2008)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
по: Alireza Komaki, и др.
Опубликовано: (2014-07-01)

Motivational interviewing for smoking cessation.
по: Lai, D, и др.
Опубликовано: (2010)